T cell depleted allogeneic PBSC transplantation using CD34+cell selection.

被引：0
|
作者：
Bensinger, W
Cornetta, K
Carabasi, M
Yanovich, S
Hughes, T
Skikne, B
Chabannon, C
Singhal, S
Mills, B
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Indiana Univ, Med Ctr, Indianapolis, IN USA
[3] Univ Alabama, Birmingham, AL USA
[4] Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA
[5] Inst Med & Vet Sci, Adelaide, SA 5000, Australia
[6] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[7] Inst J Paoli I Calmettes, F-13009 Marseille, France
[8] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[9] Nexell Therapeut Inc, Irvine, CA USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
850
引用
收藏
页码：199A / 199A
页数：1
相关论文
共 50 条
  • [31] A randomized trial comparing CD34 enriched grafts versus CD3/CD19 depleted grafts in partial T-cell depleted allogeneic stem cell transplantation
    Schaap, N.
    Eissens, D.
    Preijers, F.
    van der Meer, A.
    Schattenberg, A.
    Dolstra, H.
    van der Velden, W.
    de Witte, T.
    Smits, M.
    Blijlevens, N. M. A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S76 - S76
  • [32] Vaccines are safe and effective after T-cell depleted CD34-selected allogeneic hematopoietic stem cell transplantation (Allo HCT)
    Malard, F.
    Shah, G. L.
    Seier, K.
    Cho, C.
    Devlin, S. M.
    Maloy, M.
    Borrill, T.
    Palazzo, M.
    van den Brink, M.
    Perales, M-A
    BONE MARROW TRANSPLANTATION, 2017, 52 : S29 - S29
  • [33] CD34+CELL YIELD ON DAY 1 OF APHERESIS PREDICTS TOTAL CD34+CELL MOBILIZATION, NEUTROPHIL RECOVERY, AND SURVIVAL AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LYMPHOMA
    Dean, R.
    Rybicki, L.
    Pohlman, B.
    Sweetenham, J.
    Sobecks, R.
    Copelan, E.
    Kalaycio, M.
    Smith, S.
    andresen, S.
    Bolwell, B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 38 - 38
  • [34] CD34+cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
    Díez-Campelo, M
    Pérez-Simón, JA
    Ocio, EM
    Castilla, C
    González-Porras, JR
    Sánchez-Guijo, FM
    Vázquez, L
    Caballero, MD
    Cañizo, MC
    San Miguel, JF
    LEUKEMIA & LYMPHOMA, 2005, 46 (02) : 177 - 183
  • [35] Precise measurements of post-processing CD34+cell dose at a single site improves cord blood unit selection.
    Alonso, J. F.
    Regan, D. M.
    Wofford, J. D.
    Oliver, D. A.
    Creer, M. H.
    CYTOTHERAPY, 2006, 8
  • [36] CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts
    O'Donnell, PV
    Myers, B
    Edwards, J
    Loper, K
    Rhubart, P
    Noga, SJ
    CYTOTHERAPY, 2001, 3 (06) : 483 - 488
  • [37] Selection of CD34-positive blood cells for allogeneic transplantation:: Approaches to optimize CD34-cell recovery, purity, viability, and T-cell depletion
    Fritsch, G
    Scharner, D
    Fröschl, G
    Buchinger, P
    Peters, C
    Matthes, S
    Witt, V
    Gadner, H
    ONKOLOGIE, 2000, 23 (05): : 449 - 456
  • [38] Effect of CD34+cell dose on clinical outcomes after allogeneic hematopoietic stem cell transplantation with post-transplant cyclophosphamide
    Pedraza, A.
    Salas, M. Q.
    Rodriguez-Lobato, L. G.
    Charry, P.
    Suarez-Lledo, M.
    Martinez-Cibrian, N.
    Domenech, A.
    Solano, M. T.
    Arcarons, J.
    Llobet, N.
    Cid, J.
    Lozano, M.
    Rosinol, L.
    Gutierrez-Garcia, G.
    Urbano-Ispizua, A.
    Fernandez-Aviles, F.
    Rovira, M.
    Martinez, C.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 400 - 400
  • [39] The Effects of Shorter Cycles to Improve CD34+Cell Yields in Patients with Elevated Circulating CD34+Cell Levels Using Fenwal Amicus
    Burgstaler, E. A.
    Winters, J. L.
    TRANSFUSION, 2011, 51 : 226A - 226A
  • [40] CD34+cell selection has no impact on the outcome of autologous blood stem cell transplantation (ABSCT) in multiple myeloma (MM)
    Remes, K
    Itälä, M
    Kauppila, M
    Pelliniemi, TT
    Rajamäki, A
    BONE MARROW TRANSPLANTATION, 2002, 29 : S97 - S97
12345